GlassScriptPhysician profile
Miguel Roman
NPI 1194223248
$4,210.50
in general payments reported to CMS, 2019-2025
17 companies · $4,075 in 2025
The $4,075 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $135 · 2025: $4,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,112 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,111.50 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $790.80 | 2024-2025 | Bimzelx, Cimzia |
| Amgen INC. | $749.97 | 2024-2025 | Evenity, Uplizna, Krystexxa |
| Abbvie INC. | $676.67 | 2024-2025 | |
| Janssen Biotech, INC. | $479.04 | 2025 | Tremfya, Simponi Aria |
| E.R. Squibb & Sons, L.L.C. | $322.70 | 2025 | Orencia |
| Pfizer INC. | $213.91 | 2025 | |
| Organon LLC | $179.20 | 2024-2025 | |
| Glaxosmithkline, LLC. | $166.77 | 2024-2025 | Benlysta |
| Mallinckrodt Hospital Products INC. | $124.35 | 2024-2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $103.24 | 2025 | Saphnelo |
| Radius Health, INC. | $93.64 | 2025 | |
| Ani Pharmaceuticals, INC. | $85.05 | 2025 | Sovuna |
| Novartis Pharmaceuticals Corporation | $72.65 | 2025 | |
| Genzyme Corporation | $67.54 | 2025 | |
| Kyowa Kirin, INC. | $46.20 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $21.54 | 2025 | |
| Aurinia Pharma U.S., INC. | $17.23 | 2025 | Lupkynis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Roman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.